Pharma stocks showed strength on Thursday, defying market weakness. Dr Reddy’s Laboratories saw significant gains, fueled by anticipation of approval for its Semaglutide diabetes drug in Canada. Other pharma companies also experienced upward movement. This defensive sector appeal is attracting investors amid uncertain market conditions and geopolitical concerns.
Rupee extends gains for fourth day, closes at 95.64
The rupee closed at 95.64 on Wednesday, modestly stronger from its previous close of 95.75 after going through a choppy session post the US midterm